Accelerating clinical trials in the EU (ACT EU): transforming the EU clinical trials landscape

被引：2

作者：

Capone, Giacomo ^{[1
]}

Eriksson, Bjoern ^{[2
]}

Al, Monique ^{[3
]}

van Belkum, Stan ^{[3
]}

Broich, Karl ^{[4
]}

Lamas, Maria ^{[5
]}

Lunzer, Marianne ^{[6
]}

Nolan, Lorraine ^{[7
]}

Ester, Catriona ^{[1
]}

Burgos, Juan Garcia ^{[1
]}

Pioppo, Laura ^{[1
]}

Zanoletty, Ana ^{[1
]}

Arlett, Peter ^{[1
]}

机构：

[1] European Med Agcy, Amsterdam, Netherlands

[2] Lakemedelsverket, Uppsala, Sweden

[3] Cent Comm Res Involving Human Subjects, The Hague, Netherlands

[4] Bundesinst Arzneimittel & Med Prod, Bonn, Germany

[5] Agencia Espanola Medicamentos & Prod Sanitarios, Madrid, Spain

[6] AGES MEA, Vienna, Austria

[7] Hlth Prod Regulatory Author, Dublin, Ireland

来源：

NATURE REVIEWS DRUG DISCOVERY | 2024年 / 23卷 / 11期

关键词：

D O I：

10.1038/d41573-024-00085-5

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Accelerating Clinical Trials in the EU (ACT EU) is an initiative developed by the European Commission, Heads of Medicines Agencies and the European Medicines Agency to transform the clinical trials landscape in the European Union. It aims to foster regulatory, technological and process innovation to support better, faster and optimized clinical trials.

引用

页码：797 / 798

页数：2

共 50 条

[41] Input analysis for two public consultations on the EU Clinical Trials Regulation
Langhof, Holger
Lander, Jonas
Strech, Daniel
HEALTH RESEARCH POLICY AND SYSTEMS, 2016, 14
[42] Implications of the EU directive on clinical trials for emergency medicine -: Many trials in emergency medicine will not be possible
Singer, EA
Müllner, M
BRITISH MEDICAL JOURNAL, 2002, 324 (7347): : 1169 - 1170
[43] EU harmonises rules for trials
Watson, R
BRITISH MEDICAL JOURNAL, 2001, 322 (7278): : 68 - 68
[44] EU REGULATION OF CLINICAL TRIALS New European Union regulation of clinical trials is not conflicting on deferred consent in emergency situations
Sheehan, Mark
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
[45] Clinical Trial Data Transparency in the EU: Is the New Clinical Trials Regulation a Game-Changer?
Żaneta Zemła-Pacud
Gabriela Lenarczyk
IIC - International Review of Intellectual Property and Competition Law, 2023, 54 : 732 - 763
[46] Clinical Trial Data Transparency in the EU: Is the New Clinical Trials Regulation a Game-Changer?
Zemla-Pacud, Zaneta
Lenarczyk, Gabriela
IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW, 2023, 54 (05) : 732 - 763
[47] IMPLEMENTATION OF THE NEW EU CLINICAL TRIALS REGULATION IN SLOVAKIA: TASKS AND CHALLENGES FOR THE DISCIPLINE OF CLINICAL PHARMACOLOGY
Glasova, H.
Glasa, J.
Sobonova, K.
Krcmeryova, T.
Holoman, J.
CLINICAL THERAPEUTICS, 2015, 37 (08) : E149 - E149
[48] Clinical Trials Regulation: A Further Step towards Increased Medical Innovation in the EU
Pavlou, Anna
Saurat, Emmanuel
EUROPEAN JOURNAL OF RISK REGULATION, 2015, 6 (04) : 646 - 648
[49] European Cancer Organisation backs proposals to revise EU Clinical Trials Directive
不详
FUTURE ONCOLOGY, 2010, 6 (03) : 339 - 339
[50] European Cancer Organisation backs proposals to revise EU Clinical Trials Directive
不详
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (03) : 301 - 301

← 1 2 3 4 5 →